Home About us Contact
|
Home About us Contact | ||
|
|
||
Management Considerations (management + consideration)
Selected AbstractsEstimating angling effort and participation in a multi-user, inland fishery in South AfricaFISHERIES MANAGEMENT & ECOLOGY, Issue 1 2010B. R. ELLENDER Abstract, Angler counts, on-lake interviews and a household survey were used to estimate angler effort and participation in Lake Gariep, South Africa's largest inland water body. Annual fishing effort was estimated from instantaneous counts at 16392 angler day,1 yr,1. Recreational and subsistence anglers contributed 41 and 59% to the total annual fishing effort, respectively. Household surveys in lakeshore settlements estimated that ,914 anglers fished the lake and minimum daily fishing effort in one of the fishing areas assessed was 77 anglers. As a result of recall bias, these estimates were almost twice as high as those determined by direct counts. A low cost method of assessing participation by applying a mark,recapture model to the proportion of anglers whom had been previously interviewed during eight bimonthly sampling events was tested. The model converged in three of four applications (2 areas × 2 sectors). The mark,recapture method revealed similar numbers of anglers to the estimate of regular anglers (fishing 1,3 times a week) from the household survey and was considered an appropriate estimator for the number of subsistence anglers. Regardless of the assessment method the results show that the resource is of importance to subsistence livelihoods, which is an important management consideration in future fisheries development and rights allocation processes. [source] Genetic identification of source populations for an aquarium-traded invertebrateANIMAL CONSERVATION, Issue 1 2009D. A. Weese Abstract Increasingly, wildlife managers are turning to molecular genetics to aid in conservation efforts. While such approaches have been applied to large terrestrial and aquatic vertebrate species, their application to other traded organisms has not been extensively explored. Here, we examined the utility of these techniques for identifying source populations of aquarium ornamental invertebrates, using members of the Hawaiian atyid genus Halocaridina as a study system. These shrimps, restricted to anchialine habitats of the Hawaiian Islands, are popular in the aquarium trade due to their ability to survive in hermetically sealed containers for extended periods of time. However, commercial harvesting, coupled with habitat destruction and strong regional endemism, could lead to the depletion/extinction of unique populations. Because the land district of Kona, along the west coast of the island of Hawai'i, has the state's highest concentration of anchialine habitats, we hypothesized that commercially available Halocaridina originated from this region. To test this, mitochondrial cytochrome c oxidase subunit I gene sequences from 96 individuals, obtained from six vendors, were compared with 580 homologous sequences from previous studies covering the known distribution range of Halocaridina. Recovery of identical, regional-specific haplotypes, network analyses and statistical assignment tests identified these commercially acquired specimens as belonging to either the Kona, Ka',, (western and southern coasts, respectively, island of Hawai'i) or Kina'u (southern coast, island of Maui) genetic groups of these shrimps. Although 39 of the 96 individuals originated from the Kona genetic group as hypothesized, our finding that commercially available Halocaridina are from three genetic groups spanning two islands suggests that other populations also warrant potential management consideration. While this study represents the first application of molecular genetics in identifying source populations of aquarium ornamental species, we feel that these techniques are amenable more broadly as they are dependent on only a few caveats. [source] Surveillance for Early Detection of Aggressive Parathyroid Disease: Carcinoma and Atypical Adenoma in Familial Isolated Hyperparathyroidism Associated With a Germline HRPT2 Mutation,,JOURNAL OF BONE AND MINERAL RESEARCH, Issue 10 2006Thomas G Kelly Abstract Familial hyperparathyroid syndromes involving mutations of HRPT2 (also CDC73), a tumor suppressor, are important to identify because the relatively high incidence of parathyroid malignancy associated with such mutations warrants a specific surveillance strategy. However, there is a dearth of reports describing experience with surveillance and early detection informed by genetic insight into this disorder. Introduction: Familial isolated hyperparathyroidism (FIHP) is a rare cause of parathyroid (PT) tumors without other neoplasms or endocrinopathies. Germline mutations in CASR, MEN1, and rarely, HRPT2 have been identified in kindreds with FIHP. HRPT2 mutations may be enriched in FIHP families with PT carcinoma, underscoring the importance of identifying causative mutations. Materials and Methods: A 13-year-old boy, whose father had died of PT carcinoma, developed primary hyperparathyroidism. A left superior PT mass was identified by ultrasonography and removed surgically. Aggressive histological features of the boy's tumor included fibrous trabeculae, mitoses, and microscopic capsular infiltration. Two years later, under close biochemical surveillance, primary hyperparathyroidism recurred 5 months after documentation of normocalcemia and normal parathyroid status. Ultrasound and MRI identified a newly enlarged right superior PT gland but indicated no recurrent disease in the left neck. Histologic features typical of a benign adenoma were evident after surgical extirpation of the gland. Results: Leukocyte DNA analysis revealed a frameshift mutation in exon 2 of HRPT2. The initial tumor manifested the expected germline HRPT2 mutation, plus a distinct somatic frameshift mutation, consistent with the Knudson "two hit" concept of biallelic inactivation of a classic tumor suppressor gene. Genetic screening of the patient's 7 asymptomatic and previously normocalcemic siblings revealed three with the same germline HRPT2 mutation. One of the siblings newly identified as mutation-positive was noted to be hypercalcemic at the time of the genetic screening. He was found to have a PT adenoma with aggressive features. Two of the five children of another mutation-positive sibling also carry the same HRPT2 mutation. Conclusions: Despite the reported rarity of HRPT2 mutations in FIHP, a personal or family history of PT carcinoma in FIHP mandates serious consideration of germline HRPT2 mutation status. This information can be used in diagnostic and management considerations, leading to early detection and removal of potentially malignant parathyroid tumors. [source] Pediatric systemic lupus erythematosus: Management issues in primary practiceJOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, Issue 6 2006FNP (Instructor), Tiwaporn Pongmarutani MSN Abstract Purpose: To provide nurse practitioners (NPs) with an update on pediatric systemic lupus erythematosus (SLE) with an emphasis on management considerations for primary care practitioners. Data sources: An extensive literature review was conducted using both Medline and CINAHL databases. Research articles reflecting the most compelling findings were included in this review. Conclusions: NPs who care for children with SLE may be able to prevent or delay the morbidities associated with this disease and its treatments, if they keep abreast of the new information evolving in this realm of rheumatologic diseases. Implications for practice: As more is learned about pediatric SLE, better treatments have evolved such that the survival rates have increased. The primary care of pediatric SLE patients that is focused on preventing or delaying SLE morbidities may help to restore, maintain, or improve the quality of life for these patients. [source] Pityriasis rosea in pregnancy , specific diagnostic implications and management considerationsAUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Issue 3 2005Antonio A. T. CHUH No abstract is available for this article. [source] Pretherapy quantitative measurement of circulating Epstein,Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated typeCANCER, Issue 2 2003Sing-fai Leung M.D. Abstract BACKGROUND Patients with International Union Against Cancer (UICC) Stage I,II nasopharyngeal carcinoma (NPC) appear to have a relatively favorable prognosis and generally are excluded from trials of combined modality treatment. More recently, plasma/serum cell-free Epstein-Barr virus (EBV) DNA has been shown to be measurable in the majority of NPC patients at the time of diagnosis, and appears to have prognostic significance. However, within Stage I-II disease, in which failure events are infrequent, the prognostic impact of the pretreatment EBV DNA level has not been addressed to our knowledge. This issue has management implications because different therapeutic strategies currently are employed for patients with good-risk and those with poor-risk NPC. METHODS A cohort of 90 patients with UICC Stage I-II NPC (World Health Organization Grade 2/3 histology) had their pretherapy plasma/serum EBV DNA levels determined by a quantitative polymerase chain reaction assay and correlated with the probability of posttherapy failure. All patients received radiation therapy only, except for three patients who also received concurrent chemotherapy. Kaplan,Meier plots of the probability of locoregional failure, distant failure, and cancer-specific survival were compared with reference to clinical stage and EBV DNA levels. RESULTS With a median follow-up time of 45 months, 12 patients and 7 patients, respectively, had developed locoregional and distant failures, including 2 patients with both local and distant failures. Patients with distant failure had significantly higher pretherapy EBV DNA levels than those without failure (a median of 13,219 copies/mL [interquatile-range, 274,635 copies/mL] vs. a median of 423 copies/mL [interquatile-range, 2753 copies/mL]). The probability of distant failure was significantly higher in patients with high (> 4000 copies/mL plasma) compared with low EBV DNA levels (P = 0.0001, log-rank test) and for Stage IIB disease compared with Stage I and Stage IIA disease combined (P = 0.0149, log-rank test), but was not significantly different between patients with Stage II and those with Stage I disease. The risks of locoregional failure were not significantly different between patients with high and those with low EBV DNA levels, and also was not significantly different between clinical substages. Approximately 35% of patients with Stage IIB disease were in the at-risk group for distant failure, as identified by high EBV DNA levels. CONCLUSIONS Within a group of patients with UICC Stage I-II NPC, the pretherapy plasma EBV DNA level was found to identify a poor-risk group with a probability of distant failure similar to that of patients with advanced stage disease. This group of patients may warrant management considerations currently applicable only to cases of Stage III-IV disease. The prognostic significance of designating Stage IIB disease as per the 1997 UICC staging was confirmed, although the pretherapy EBV DNA level appears to be a more powerful prognostic discriminator in patients with early-stage NPC. Cancer 2003;98:288,91. © 2003 American Cancer Society. DOI 10.1002/cncr.11496 [source] | ||||||||||